Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – Direct comparison of doxorubicin-loaded nanobubbles and microbubbles
Issued Date
2024-03-01
Resource Type
ISSN
01683659
eISSN
18734995
Scopus ID
2-s2.0-85183205825
Pubmed ID
38237687
Journal Title
Journal of Controlled Release
Volume
367
Start Page
135
End Page
147
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Controlled Release Vol.367 (2024) , 135-147
Suggested Citation
Nittayacharn P., Abenojar E., Cooley M.B., Berg F.M., Counil C., Sojahrood A.J., Khan M.S., Yang C., Berndl E., Golczak M., Kolios M.C., Exner A.A. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – Direct comparison of doxorubicin-loaded nanobubbles and microbubbles. Journal of Controlled Release Vol.367 (2024) , 135-147. 147. doi:10.1016/j.jconrel.2024.01.028 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/95691
Title
Efficient ultrasound-mediated drug delivery to orthotopic liver tumors – Direct comparison of doxorubicin-loaded nanobubbles and microbubbles
Corresponding Author(s)
Other Contributor(s)
Abstract
Liver metastasis is a major obstacle in treating aggressive cancers, and current therapeutic options often prove insufficient. To overcome these challenges, there has been growing interest in ultrasound-mediated drug delivery using lipid-shelled microbubbles (MBs) and nanobubbles (NBs) as promising strategies for enhancing drug delivery to tumors. Our previous work demonstrated the potential of Doxorubicin-loaded C3F8 NBs (hDox-NB, 280 ± 123 nm) in improving cancer treatment in vitro using low-frequency unfocused therapeutic ultrasound (TUS). In this study, we investigated the pharmacokinetics and biodistribution of sonicated hDox-NBs in orthotopic rat liver tumors. We compared their delivery and therapeutic efficiency with size-isolated MBs (hDox-MB, 1104 ± 373 nm) made from identical shell material and core gas. Results showed a similar accumulation of hDox in tumors treated with hDox-MBs and unfocused therapeutic ultrasound (hDox-MB + TUS) and hDox-NB + TUS. However, significantly increased apoptotic cell death in the tumor and fewer off-target apoptotic cells in the normal liver were found upon the treatment with hDox-NB + TUS. The tumor-to-liver apoptotic ratio was elevated 9.4-fold following treatment with hDox-NB + TUS compared to hDox-MB + TUS, suggesting that the therapeutic efficacy and specificity are significantly increased when using hDox-NB + TUS. These findings highlight the potential of this approach as a viable treatment modality for liver tumors. By elucidating the behavior of drug-loaded bubbles in vivo, we aim to contribute to developing more effective liver cancer treatments that could ultimately improve patient outcomes and decrease off-target side effects.